Abstract:Diabetic retinopathy (DR) is the most common reason for blindness in working-age individuals globally. Prolonged high blood glucose is a main causative factor for DR development, and glucose transport is prerequisite for the disturbances in DR caused by hyperglycemia. Glucose transport is mediated by its transporters, including the facilitated transporters (glucose transporter, GLUTs), the "active" glucose transporters (sodium-dependent glucose transporters, SGLTs), and the SLC50 family of uniporters (sugars will eventually be exported transporters, SWEETs). Glucose transport across the blood-retinal barrier (BRB) is crucial for nourishing the neuronal retina in the context of retinal physiology. This physiological process primarily relies on GLUTs and SGLTs, which mediate the glucose transportation across both the cell membrane of retinal capillary endothelial cells and the retinal pigment epithelium (RPE). Under diabetic conditions, increased accumulation of extracellular glucose enhances the retinal cellular glucose uptake and metabolism via both glycolysis and glycolytic side branches, which activates several biochemical pathways, including the protein kinase C (PKC), advanced glycation end-products (AGEs), polyol pathway and hexosamine biosynthetic pathway (HBP). These activated biochemical pathways further increase the production of reactive oxygen species (ROS), leading to oxidative stress and activation of Poly (ADP-ribose) polymerase (PARP). The activated PARP further affects all the cellular components in the retina, and finally resulting in microangiopathy, neurodegeneration and low-to-moderate grade inflammation in DR. This review aims to discuss the changes of glucose transport, glucose transporters, as well as its metabolism in DR, which influences the retinal neurovascular unit (NVU) and implies the possible therapeutic strategies for treating DR.

Aldehyde Dehydrogenase and Aldo-Keto Reductase Enzymes: Basic Concepts and Emerging Roles in Diabetic Retinopathy

The Role of Lipoxidation in the Pathogenesis of Diabetic Retinopathy

Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review

Acrolein: A Potential Mediator of Oxidative Damage in Diabetic Retinopathy

Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Implications of Diabetes-Induced Altered Metabolites on Retinal Neurodegeneration

The Roles of Aldose Reductase in Diabetic Retinopathy

Molecular mechanisms of diabetic retinopathy: Potential therapeutic targets

Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects

Redox signaling in diabetic retinopathy and opportunity for therapeutic intervention through natural products

Arteriolar Involvement in the Microvascular Lesions of Diabetic Retinopathy: Implications for Pathogenesis

Relationship between Biochemical Pathways and Non-Coding RNAs Involved in the Progression of Diabetic Retinopathy

Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets

Redoxisome and diabetic retinopathy: Pathophysiology and therapeutic interventions

Emerging Roles of Dyslipidemia and Hyperglycemia in Diabetic Retinopathy: Molecular Mechanisms and Clinical Perspectives

Endothelial to mesenchymal cell transition in diabetic retinopathy: targets and therapeutics

Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective

Diabetic retinopathy: current understanding, mechanisms, and treatment strategies

Glucose transport, transporters and metabolism in diabetic retinopathy

Advancement in Understanding Diabetic Retinopathy: A Comprehensive Review

Pathological Role of Unsaturated Aldehyde Acrolein in Diabetic Retinopathy